摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-溴-1-萘甲酸甲酯 | 35615-97-5

中文名称
4-溴-1-萘甲酸甲酯
中文别名
4-溴-1-萘酸甲酯
英文名称
methyl 4-bromo-1-naphthoate
英文别名
4-bromo-naphthalene-1-carboxylic acid methyl ester;methyl 4-bromonaphthalene-1-carboxylate
4-溴-1-萘甲酸甲酯化学式
CAS
35615-97-5
化学式
C12H9BrO2
mdl
——
分子量
265.106
InChiKey
NSWYFJWAOXYZDF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    370.8±15.0 °C(Predicted)
  • 密度:
    1.492±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.7
  • 重原子数:
    15
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.08
  • 拓扑面积:
    26.3
  • 氢给体数:
    0
  • 氢受体数:
    2

安全信息

  • 危险品标志:
    Xi
  • 海关编码:
    2916399090
  • 危险性防范说明:
    P280,P305+P351+P338
  • 危险性描述:
    H302
  • 储存条件:
    室温且干燥

SDS

SDS:aa05930efee70f46de82d28a66d65ff9
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: Methyl 4-bromo-1-naphthoate
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: Methyl 4-bromo-1-naphthoate
CAS number: 35615-97-5

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C12H9BrO2
Molecular weight: 265.1

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, hydrogen bromide.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    • 1
    • 2

反应信息

  • 作为反应物:
    描述:
    4-溴-1-萘甲酸甲酯 在 potassium hydroxide 、 盐酸 作用下, 以 为溶剂, 反应 12.0h, 以73%的产率得到4-溴-1-萘甲酸
    参考文献:
    名称:
    Synthesis and pharmacology of 1-alkyl-3-(1-naphthoyl)indoles: Steric and electronic effects of 4- and 8-halogenated naphthoyl substituents
    摘要:
    To develop SAR at both the cannabinoid CB1 and CB2 receptors for 3-(1-naphthoyl)indoles bearing moderately electron withdrawing substituents at C-4 of the naphthoyl moiety, 1-propyl and 1-pentyl-3-(4-fluoro, chloro, bromo and iodo-1-naphthoyl) derivatives were prepared. To study the steric and electronic effects of substituents at the 8-position of the naphthoyl group, the 3-(4-chloro, bromo and iodo-1-naphthoyl) indoles were also synthesized. The affinities of both groups of compounds for the CB1 and CB2 receptors were determined and several of them were evaluated in vivo in the mouse. The effects of these substituents on receptor affinities and in vivo activity are discussed and structure-activity relationships are presented. Although many of these compounds are selective for the CB2 receptor, only three JWH-423, 1-propyl-3-(4-iodo-1-naphthoyl)indole, JWH-422, 2-methyl-1-propyl-3-(4-iodo-1-naphthoyl) indole, the 2-methyl analog of JWH-423 and JWH-417, 1-pentyl-3-(8-iodo-1-naphthoyl)indole, possess the desirable combination of low CB1 affinity and good CB2 affinity. (C) 2012 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2012.01.038
  • 作为产物:
    描述:
    参考文献:
    名称:
    发现新型口服活性双重NK1 / NK2拮抗剂。
    摘要:
    对选择性NK2拮抗剂SR48968和ZD7944周围SAR的探索导致发现萘1酰胺类似物可提供有效的NK1和NK2双重拮抗剂。ZD6021抑制[3H] -NKA或[3H] -SP与人NK1和NK2受体的结合,并具有高亲和力(分别为K(i)= 0.12和0.62nM)。在功能测定中,对于人NK1和NK2,ZD6021在10(-7)M时的人肺动脉pK(B)= 8.9和人支气管pK(B)= 7.3。对豚鼠口服ZD6021剂量依赖性减弱ASMSP诱导的血浆蛋白外渗,ED(50)= 0.5mg / kg,NK2介导的支气管收缩,ED(50)= 13mg / kg。
    DOI:
    10.1016/s0960-894x(01)00572-8
点击查看最新优质反应信息

文献信息

  • Palladium-Catalyzed Cascade Dearomative Spirocyclization and C−H Annulation of Aromatic Halides with Alkynes
    作者:Xingrong Liao、Fulin Zhou、Zhengyang Bin、Yudong Yang、Jingsong You
    DOI:10.1021/acs.orglett.1c01736
    日期:2021.7.2
    Described herein is a palladium-catalyzed intermolecular dearomative annulation of aryl halides with alkynes, which provides a rapid approach to a class of structurally unique spiroembedded polycyclic aromatic compounds. The cascade process is accomplished by a sequential alkyne migratory insertion, Heck-type dearomatization, and C–H bond annulation. Further optoelectronic study indicated this fused
    本文描述的是钯催化的芳基卤化物与炔的分子间脱芳环化,这提供了一种快速制备一类结构独特的螺嵌入多环芳族化合物的方法。级联过程是通过连续的炔迁移插入、Heck 型脱芳构化和 C-H 键环化来完成的。进一步的光电研究表明,这种稠合螺环支架可能是 OLED 的潜在主体材料,例如最大外量子效率为 23.0% 的红色 PhOLED 器件。
  • Highly selective electroreductive linear dimerization of electron-deficient vinylarenes
    作者:Shulin Ning、Lianyou Zheng、Ya Bai、Shutao Wang、Siyu Wang、Lingling Shi、Qiansong Gao、Xin Che、Zhuoqi Zhang、Jinbao Xiang
    DOI:10.1016/j.tet.2021.132535
    日期:2021.12
    A direct electroreductive dimerization of electron-deficient vinylarenes for the synthesis of 1,4-diarylbutane has been developed using a simple undivided cell with inexpensive carbon electrodes at room temperature. The control and deuterium-labeling experiments of electroreductive dimerization suggest that the hydrogen source comes from the solvent CH3CN. This protocol provides a mild and efficient
    在室温下,使用具有廉价碳电极的简单未分隔电池开发了用于合成 1,4-二芳基丁烷的缺电子乙烯基芳烃的直接电还原二聚反应。电还原二聚的控制和氘标记实验表明氢源来自溶剂CH 3 CN。该方案为以中等至良好的产率构建 C-C 键提供了一种温和有效的途径,具有高区域选择性和广泛的底物范围。
  • N-substituted naphthalene carboxamides as neurokinin-receptor antagonists
    申请人:Astra Zeneca AB
    公开号:US06365602B1
    公开(公告)日:2002-04-02
    A compound of formula I wherein: R is alkyl; R1 is optionally substituted phenyl 2-oxo-tetrahydro-1(2H)-pyrimidinyl, or 2-oxo-1-piperidinyl; R2 is hydrogen, alkoxy, alkanoyloxy, alkoxycarbonyl, alkanoylamino, acyl, alkyl, carbamoyl, N-alkylcarbamoyl, N,N-dialkylcarbamoyl where the alkyl groups are the same or different, hydroxy, thioacyl, thiocarbamoyl, N-alkylthiocarbamoyl, or N,N-dialkylthiocarbamoyl where the alkyl groups are the same or different. X1 and X2 are independently hydrogen or halo, provided that at least one of X1 or X2 is halo; and R3, R4, R5 and R6 are independently hydrogen, cyano, nitro, trifluoromethoxy, trifluoromethyl, or alkylsulfonyl are antagonists of at least one tachykinin receptor and are useful in the treatment of depression, anxiety, asthma, pain, inflammation, urinary incontinence and other disease conditions. Process for their preparation are described, as are compositions containing them and their use.
    公式I的化合物中:R是烷基;R1是可选择地取代的苯基2-氧代四氢-1(2H)-嘧啶基,或2-氧代-1-哌啶基;R2是氢、烷氧基、烷酰氧基、烷氧羰基、烷酰胺基、酰基、烷基、氨基甲酰基、N-烷基氨基甲酰基、N,N-二烷基氨基甲酰基(其中烷基基团相同或不同)、羟基、硫代酰基、硫代氨基甲酰基、N-烷基硫代氨基甲酰基、或N,N-二烷基硫代氨基甲酰基(其中烷基基团相同或不同)。X1和X2独立地为氢或卤素,但至少X1或X2中的一个为卤素;R3、R4、R5和R6独立地为氢、氰基、硝基、三氟甲氧基、三氟甲基、或烷基磺酰基,它们是至少一种催吐肽受体的拮抗剂,对治疗抑郁症、焦虑症、哮喘、疼痛、炎症、尿失禁和其他疾病情况有用。描述了它们的制备方法,以及含有它们和它们的用途的组合物。
  • From Acenaphthenes to (+)-Delavatine A: Visible-Light-Induced Ring Closure of Methyl (α-Naphthyl) Acrylates
    作者:Theodor Peez、Jan-Niclas Luy、Klaus Harms、Ralf Tonner、Ulrich Koert
    DOI:10.1002/chem.201804735
    日期:2018.12.3
    Disclosed herein is a visible light mediated cyclization of methyl (α‐naphthyl) acrylates and heteroaromatic analogues yielding substituted acenaphthenes and azaacenaphthenes. This highly functional‐group‐tolerant transformation was put to the test in an enantioselective formal synthesis of delavatine A. Mechanistic details were elucidated by DFT‐calculations revealing an unusual intramolecular H‐transfer
    本文公开了可见光介导的丙烯酸(α-萘基)丙烯酸酯和杂芳族类似物的环化反应,产生取代的substituted啶和氮杂za啶。这种对官能团具有高度耐受性的转化被用于法拉第汀A的对映选择性正式合成中。通过DFT计算阐明了机理细节,揭示了伯胺介导的异常分子内H转移。这种转变的普遍性使得在晚期可以进行五元环空环合成的新颖合成策略,从而允许对萘化学的依赖直至of的构建。
  • Synthesis and Biological Effects of Novel 2-Amino-3-naphthoylthiophenes as Allosteric Enhancers of the A<sub>1</sub> Adenosine Receptor
    作者:Pier Giovanni Baraldi、Romeo Romagnoli、Maria Giovanna Pavani、Maria del Carmen Nuñez、Mojgan Aghazadeh Tabrizi、John C. Shryock、Edward Leung、Allan R. Moorman、Canan Uluoglu、Valeria Iannotta、Stefania Merighi、Pier Andrea Borea
    DOI:10.1021/jm0210212
    日期:2003.2.1
    cycloalkylthiophenes, tetrahydrobenzo[b]thiophene derivatives appeared to be more potent than the dihydrocyclopentadien[b]thiophene counterparts. Some of the most potent compounds were tested at a concentration of 10 microM for their affinity as competitors to the antagonist binding site of CHO cells expressing hA(1), hA(2A), and hA(3) adenosine receptors. None inhibited binding at the hA(2A)AR, but most
    当前的研究描述了一系列新型的2-氨基-3-萘噻吩并在噻吩的4-位和5-位以及萘环上有可变的修饰。以多种方式测量了变构增强子的活性:(1)在表达克隆的人A(C)的中国仓鼠卵巢(CHO)细胞中,在A(1)-腺苷激动剂(CPA)存在的情况下评估对福司柯林刺激的cAMP积累的影响。 1)-腺苷受体(hA(1)AR); (2)这些化合物取代[(3)H] DPCPX,[(3)H] ZM 241385和[(3)H] MRE 3008F20与表达hA( 1),hA(2A)和hA(3)腺苷受体;(3)对[(3)H] CCPA与表达hA(1)AR的CHO细胞膜结合的影响,含有天然腺苷A(1)受体的大鼠大脑和人类皮质膜制剂;(4)[(3)H] CCPA从CHO-hA1膜解离的动力学。药理分析比较了各种活性与参考化合物PD 81,723(化合物1)的活性。在CHO:hA(1)分析中,几种化合物似乎比PD 81,7
查看更多